Aerovate Therapeutics, Inc.
INHALABLE FORMULATIONS OF IMATINIB, IMATINIB METABOLITES, IMATINIB SALTS, THEIR MANUFACTURE, AND USES THEREOF

Last updated:

Abstract:

The invention generally relates to inhalable formulations of imatinib, imatinib metabolites, imatinib salts, their manufacture, and uses thereof.

Status:
Application
Type:

Utility

Filling date:

14 May 2020

Issue date:

19 Nov 2020